Trial · NCT00965419
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain upper | Gastrointestinal disorders | Edivoxetine (Open-Label) | 22 | 264 | 28 |
| other | Abdominal pain upper | Gastrointestinal disorders | Edivoxetine (Follow Up) | 2 | 80 | 2 |
| other | Nausea | Gastrointestinal disorders | Edivoxetine (Open-Label) | 35 | 264 | 48 |
| other | Nausea | Gastrointestinal disorders | Edivoxetine (Follow Up) | 0 | 80 | 0 |
| other | Vomiting | Gastrointestinal disorders | Edivoxetine (Open-Label) | 45 | 264 | 69 |
| other | Vomiting | Gastrointestinal disorders | Edivoxetine (Follow Up) | 0 | 80 | 0 |
| other | Fatigue | General disorders | Edivoxetine (Open-Label) | 16 | 264 | 19 |
| other | Fatigue | General disorders | Edivoxetine (Follow Up) | 0 | 80 | 0 |
| other | Gastroenteritis viral | Infections and infestations | Edivoxetine (Open-Label) | 15 | 264 | 17 |
| other | Gastroenteritis viral | Infections and infestations | Edivoxetine (Follow Up) | 0 | 80 | 0 |
| other | Nasopharyngitis | Infections and infestations | Edivoxetine (Open-Label) | 18 | 264 | 28 |
| other | Nasopharyngitis | Infections and infestations | Edivoxetine (Follow Up) | 0 | 80 | 0 |
| other | Pharyngitis streptococcal | Infections and infestations | Edivoxetine (Open-Label) | 15 | 264 | 19 |
| other | Pharyngitis streptococcal | Infections and infestations | Edivoxetine (Follow Up) | 0 | 80 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | Edivoxetine (Open-Label) | 35 | 264 | 44 |
| other | Upper respiratory tract infection | Infections and infestations | Edivoxetine (Follow Up) | 2 | 80 | 2 |
| other | Decreased appetite | Metabolism and nutrition disorders | Edivoxetine (Open-Label) | 15 | 264 | 16 |
| other | Decreased appetite | Metabolism and nutrition disorders | Edivoxetine (Follow Up) | 1 | 80 | 1 |
| other | Headache | Nervous system disorders | Edivoxetine (Open-Label) | 45 | 264 | 61 |
| other | Headache | Nervous system disorders | Edivoxetine (Follow Up) | 0 | 80 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00965419/events